Skip to Content
Merck
CN

AT

BMC cardiovascular disorders (2017-05-19)
Kristoffer Bernhem, Kalaiselvan Krishnan, Alexander Bondar, Hjalmar Brismar, Anita Aperia, Lena Scott
PMID28514967
ABSTRACT

Blockers of angiotensin II type 1 receptor (AT To elucidate these questions, we have studied the Ca Repeated exposure to pharmacological (100 nM) concentrations of AngII caused, as expected, a down-regulation of the Ca Our findings have implications for the understanding of hyperactivity of the angiotensin system and for use of Ca